Table 2 Treatment characteristics and outcomes of patients experiencing locoregional recurrence (LRR) or distant metastasis (DM) as first recurrence of adenoid cystic carcinoma
From: Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinoma
LRR (n = 20) | p value | DM (n = 16) | p value | |
|---|---|---|---|---|
Treatment | ||||
Surgery | 10 | 5 | ||
Surgery + PORT | 8 | 0 | ||
RT alone | 1 | 4 | ||
CF-RT | 1 | 0 | ||
SBRT | 0 | 2 | ||
Palliative RT | 0 | 2 | ||
Systemic therapy alone | 1 | 1 | ||
Observation | 0 | 6 | ||
3-year PFS | 82.1% | 61.2% | ||
3-year PFS | ||||
Low-risk | 100% | 0.15 | 80.0% | 0.48 |
High-risk | 64.3% | 44.4% | ||
3-year OS | 73.3% | 85.1% | ||
3-year OS | ||||
Low-risk | 87.5% | 0.01 | 100% | 0.03 |
High-risk | 62.3% | 76.2% | ||